313 related articles for article (PubMed ID: 24304186)
1. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.
Ubhi K; Rockenstein E; Kragh C; Inglis C; Spencer B; Michael S; Mante M; Adame A; Galasko D; Masliah E
Eur J Neurosci; 2014 Mar; 39(6):1026-1041. PubMed ID: 24304186
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.
Kim T; Valera E; Desplats P
Mol Neurobiol; 2019 Oct; 56(10):7003-7021. PubMed ID: 30968343
[TBL] [Abstract][Full Text] [Related]
3. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.
Schafferer S; Khurana R; Refolo V; Venezia S; Sturm E; Piatti P; Hechenberger C; Hackl H; Kessler R; Willi M; Gstir R; Krogsdam A; Lusser A; Poewe W; Wenning GK; Hüttenhofer A; Stefanova N
PLoS One; 2016; 11(3):e0150705. PubMed ID: 26962858
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy.
Valera E; Spencer B; Mott J; Trejo M; Adame A; Mante M; Rockenstein E; Troncoso JC; Beach TG; Masliah E; Desplats P
Front Mol Neurosci; 2017; 10():329. PubMed ID: 29089869
[TBL] [Abstract][Full Text] [Related]
5. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
6. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro.
Wei YB; Melas PA; Villaescusa JC; Liu JJ; Xu N; Christiansen SH; Elbrønd-Bek H; Woldbye DP; Wegener G; Mathé AA; Lavebratt C
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27507301
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA expression profiling in patients with multiple system atrophy.
Kume K; Iwama H; Deguchi K; Ikeda K; Takata T; Kokudo Y; Kamada M; Fujikawa K; Hirose K; Masugata H; Touge T; Masaki T
Mol Med Rep; 2018 Jan; 17(1):852-860. PubMed ID: 29115515
[TBL] [Abstract][Full Text] [Related]
9. Altered microRNA regulation in Huntington's disease models.
Lee ST; Chu K; Im WS; Yoon HJ; Im JY; Park JE; Park KH; Jung KH; Lee SK; Kim M; Roh JK
Exp Neurol; 2011 Jan; 227(1):172-9. PubMed ID: 21035445
[TBL] [Abstract][Full Text] [Related]
10. The role of the protein-RNA recognition code in neurodegeneration.
Nahalka J
Cell Mol Life Sci; 2019 Jun; 76(11):2043-2058. PubMed ID: 30980111
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
Weng YT; Chang YM; Chern Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
13. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
[TBL] [Abstract][Full Text] [Related]
15. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
16. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated miRNA and mRNA Expression Affect Overlapping Pathways in a Huntington's Disease Model.
Zsindely N; Nagy G; Siági F; Farkas A; Bodai L
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569316
[TBL] [Abstract][Full Text] [Related]
18. microRNA dysregulation in neurodegenerative diseases: A systematic review.
Juźwik CA; S Drake S; Zhang Y; Paradis-Isler N; Sylvester A; Amar-Zifkin A; Douglas C; Morquette B; Moore CS; Fournier AE
Prog Neurobiol; 2019 Nov; 182():101664. PubMed ID: 31356849
[TBL] [Abstract][Full Text] [Related]
19. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
